Bioceres Crop Solutions Corp
NASDAQ:BIOX
Intrinsic Value
Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. [ Read More ]
The intrinsic value of one
BIOX
stock under the Base Case scenario is
29.27
USD.
Compared to the current market price of 11.97 USD,
Bioceres Crop Solutions Corp
is
Undervalued by 59%.
Bioceres Crop Solutions Corp's market capitalization is 752.3m USD.
BIOX stock price is 11.97 USD.
BIOX stock price (11.97 USD) is 59% less than its Intrinsic Value (29.27 USD).
BIOX stock price (11.97 USD) is 60% less than its Relative Value (30.2 USD). Open Relative Valuation
BIOX has upside potential of 73% compared to the average analyst price target.
Open Wall St Estimates
BIOX's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 8%.
BIOX's ROE (Return on Equity) for the past 12 months is positive and is equal to 8%.
BIOX has positive Operating Income for the last twelve months.
BIOX's Revenue has grown by 16% over the past 12 months.
BIOX's short-term assets (392m USD) exceed its short-term liabilties (318m USD).
BIOX's long-term assets (817m USD) exceed its long-term liabilties (517m USD).
BIOX's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from -6% to 8%.
BIOX has positive Net Income for the last twelve months.
BIOX's Revenue is forecast to grow at a rate of 24% per year over the next 3 years.
BIOX's ROE (Return on Equity) has significantly increased in the last 3 years from -10% to 8%.
BIOX has positive Net Debt. This means that the company has more debt (119m USD) than cash and short-term investments (41m USD).
BIOX has positive Gross Profit for the last twelve months.
BIOX's Altman Z-Score is equal to 1.82.
BIOX has negative three-year average ROE (Return on Equity): -2%. The company is not efficient at transforming stockholders' equity into net income.
BIOX's Revenue has been growing by an exceptional 40% per year for the last 3 years.
BIOX has positive Free Cash Flow for the last twelve months.
BIOX has negative three-year average ROIC (Return on Invested Capital): -7%. The company is not efficient at using invested capital to generate operating income.
BIOX's D/E (Debt to Equity) is very low and is equal to 0.4.
BIOX generates enough operating income (55m USD) to cover interest payments on its debt (23m USD).
Valuation Backtest
Bioceres Crop Solutions Corp
Run backtest to discover the historical profit from buying and selling
BIOX
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Bioceres Crop Solutions Corp
Balance Sheet Decomposition
Bioceres Crop Solutions Corp
| Current Assets | 391.9m |
| Cash & Short-Term Investments | 41.4m |
| Receivables | 225.7m |
| Other Current Assets | 124.8m |
| Non-Current Assets | 425.3m |
| Long-Term Investments | 42.8m |
| PP&E | 88.9m |
| Intangibles | 284.9m |
| Other Non-Current Assets | 8.7m |
| Current Liabilities | 318.2m |
| Accounts Payable | 164m |
| Accrued Liabilities | 8.2m |
| Other Current Liabilities | 146m |
| Non-Current Liabilities | 198.4m |
| Long-Term Debt | 119.1m |
| Other Non-Current Liabilities | 79.3m |
Earnings Waterfall
Bioceres Crop Solutions Corp
|
Revenue
|
452m
USD
|
|
Cost of Revenue
|
-261m
USD
|
|
Gross Profit
|
190.9m
USD
|
|
Operating Expenses
|
-136.2m
USD
|
|
Operating Income
|
54.8m
USD
|
|
Other Expenses
|
-32.8m
USD
|
|
Net Income
|
21.9m
USD
|
Free Cash Flow Analysis
Bioceres Crop Solutions Corp
What is Free Cash Flow?
BIOX Profitability Score
Profitability Due Diligence
Bioceres Crop Solutions Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Bioceres Crop Solutions Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
BIOX Solvency Score
Solvency Due Diligence
Bioceres Crop Solutions Corp's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Bioceres Crop Solutions Corp's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BIOX Price Targets Summary
Bioceres Crop Solutions Corp
According to Wall Street analysts, the average 1-year price target for
BIOX
is 20.66 USD
with a low forecast of 17.17 USD and a high forecast of 26.25 USD.
Shareholder Return
BIOX Price
Bioceres Crop Solutions Corp
| Average Annual Return | 34.59% |
| Standard Deviation of Annual Returns | 65.83% |
| Max Drawdown | -41% |
| Market Capitalization | 752.3m USD |
| Shares Outstanding | 60 570 000 |
| Percentage of Shares Shorted | 1.22% |
Company Profile
Bioceres Crop Solutions Corp
Country
Industry
Market Cap
Dividend Yield
Description
Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. The company is headquartered in Rosario, Santa Fe. The company went IPO on 2018-03-22. The Company’s solutions include seeds, seed traits, seed treatments, biologicals, adjuvants and fertilizers. Through its subsidiary Rizobacter, it operates through Brazil and Paraguay. Through the Rizobacter brand, it produces and sells soybean biologicals.
Contact
IPO
Employees
Officers
The intrinsic value of one
BIOX
stock under the Base Case scenario is
29.27
USD.
Compared to the current market price of 11.97 USD,
Bioceres Crop Solutions Corp
is
Undervalued by 59%.
You don't have any saved screeners yet
